The National Cancer Screening Register Act 2016 (the NCSR Act), includes a requirement for prescribed healthcare providers to notify prescribed information to the Commonwealth Chief Medical Officer (CMO) within a prescribed timeframe. The NCSR Rules 2017 requires notification of all colposcopy episodes to the Register.Close FAQ
The NCSR Rules 2017 requires colposcopists to notify an individual’s screening test information, results of follow-up procedures, diagnosis (or clearance) of cancer, and treatment information in relation to pre-cancerous abnormalities.
A revised notification requirement and reporting form will be introduced on 1 December 2018. This requirement will facilitate the collection of additional information including Aboriginal and/or Torres Strait Islander status, country of origin and preferred language of individuals, if known.
This information must be lodged with the Register using the Colposcopy & Treatment form which is the approved form for this purpose under section 25 of the NCSR Act.Close FAQ
Colposcopists will be able to extract their performance data from the Register and submit this data to C-QuIP for certification purposes.
The information provided will inform participant clinical pathways and support the safety net function of the Register. Colposcopy notification will also enable quality and safety monitoring of the NCSP across the cervical screening pathway, and support high quality service delivery through monitoring of the colposcopy diagnostic and therapeutic standards and targets.
From 2019, colposcopists will receive reports detailing their performance data from the Register and can submit this data to C-QuIP for certification purposes.Close FAQ
The new requirement to notify, if known, Aboriginal and/or Torres Strait Islander status, country of origin and preferred language is due to commence 1 December 2018.
The prescribed information must be notified within 14 days after the colposcopy is carried out (referred to as colposcopy episode). A colposcopy episode (whether diagnostic or therapeutic)is a single appointment where a colposcopy has been performed.
Colposcopists do not need to wait for pathology information or outcomes from a future appointment in order to submit a form on the current colposcopy episode.Close FAQ
Completed forms can be faxed to 1800 627 702 or posted to the National Cancer Screening Register, Reply Paid 90964, SUNSHINE VIC 3020
If you have returned the form via fax, please check the electronic receipt provided by your fax machine to ensure that the form has been sent successfully.
It is not currently possible for the National Cancer Screening Register to provide acknowledgement of receipt of forms received via mail by post. Please ensure that the form is sent to the correct address to the National Cancer Screening Register, Reply Paid 90964, SUNSHINE VIC 3020
The National Cancer Screening Register will be able to provide colposcopists with a receipt of acknowledgement in future. We will keep colposcopists informed of updates to register functions.Close FAQ
The Act creates an offense for non-compliance with the notification requirement. Please be aware that penalty fines may apply from 1 May 2018.